Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: Indications, outcomes, and role in patient management

American Journal of Roentgenology

Volumn 187, Issue 3, 2006, Pages 746-750

  Gervais, Debra A ^a   Arellano, Ronald S ^a   Mueller, Peter R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Oncology; Ovarian neoplasm; Percutaneous ablation; Radiofrequency ablation

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; OUTCOMES RESEARCH; OVARY CANCER; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT INDICATION; CATHETER ABLATION; FEMALE; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33748455091     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.1106     Document Type: Article

References (12)

1. Van der Burg MEL, van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995; 332:629-634
2. Gungor M, Ortac F, Arvas M, Kosebay D, Sonmezer M, Kose K. The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol 2005; 97:74-79
3. Gronlund B, Lundvall L, Christensen IJ, Knudsen JB, Hogdall C. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Eur J Surg Oncol 2005; 31:67-73
4. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003; 90:390-396
5. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach." Cancer 2003; 97:3027-3035
6. Bojalian MO, Machado GR, Swensen R, Reeves ME. Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. Gynecol Oncol 2004; 93:557-560
7. Mahnken AH, Buecker A, Spuentrup E, et al. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results. J Magn Reson Imaging 2004; 19:342-348
8. Jacobs IA, Chang CK, Salti G. Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors. Am Surg 2003; 69:416-418
9. Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of nodal metastases. Cardiovasc Intervent Radiol 2002; 25:547-549
10. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235:728-739
11. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10:52-58
12. Rose PG, Nerenstone S, Brady MF, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004; 351:2489-2497